Tharimmune Stock Analysis

Tharimmune Stock Analysis Notes

The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tharimmune recorded earning per share (EPS) of 61.01. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 28th of May 2024. To find out more about Tharimmune contact the company at 908 955 3140 or learn more at https://www.tharimmune.com.

Tharimmune Investment Alerts

Tharimmune Upcoming and Recent Events

Tharimmune Largest EPS Surprises

View All Earnings Estimates

Tharimmune Environmental, Social, and Governance (ESG) Scores

Tharimmune Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.42 M.

Tharimmune Profitablity

Management Efficiency

Tharimmune has return on total asset (ROA) of (1.6508) % which means that it has lost $1.6508 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5453) %, meaning that it created substantial loss on money invested by shareholders. Tharimmune's management efficiency ratios could be used to measure how well Tharimmune manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/28/2024, Return On Tangible Assets is likely to drop to -0.89. In addition to that, Return On Capital Employed is likely to grow to -0.98. At this time, Tharimmune's Total Assets are relatively stable compared to the past year. As of 11/28/2024, Net Tangible Assets is likely to grow to about 6.7 M, while Other Current Assets are likely to drop slightly above 10.5 K.

Technical Drivers

As of the 28th of November, Tharimmune has the Risk Adjusted Performance of 0.0172, coefficient of variation of 9623.15, and Semi Deviation of 5.36. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tharimmune, as well as the relationship between them. Please validate Tharimmune variance, as well as the relationship between the value at risk and skewness to decide if Tharimmune is priced more or less accurately, providing market reflects its prevalent price of 2.26 per share. Please also confirm Tharimmune total risk alpha, which is currently at (1.56) to double-check the company can sustain itself at a future point.

Tharimmune Price Movement Analysis

Tharimmune Insider Trading Activities

Tharimmune Predictive Daily Indicators

Tharimmune Corporate Filings

Tharimmune Forecast Models

Tharimmune's time-series forecasting models are one of many Tharimmune's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tharimmune's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tharimmune prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tharimmune shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tharimmune. By using and applying Tharimmune Stock analysis, traders can create a robust methodology for identifying Tharimmune entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tharimmune analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tharimmune analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tharimmune stock analysis indicators help investors evaluate how Tharimmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tharimmune shares will generate the highest return on investment. By understating and applying Tharimmune stock analysis, traders can identify Tharimmune position entry and exit signals to maximize returns.

When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.